Cryopreservation of Hematopoietic Stem Cells

Laboratory products

Cryopreservation of Hematopoietic Stem Cells

28 Feb, 2018

Published over 8 years ago. See the latest and most current information on Laboratory products.

HSC-BANKER® from Amsbio is a new optimised GMP grade cryopreservation medium for the banking of hematopoietic stem cells isolated from umbilical cord blood, peripheral blood and bone marrow.

In a comparative study on the cryopreservation of hematopoietic stem cells, performed by the Cord Blood Bank of the Japanese Red Cross Society, results using HSC-BANKER® were shown to at least equivalent to conventional protocols using DMSO and DEXTRAN.

Manufactured to be completely free of serum and animal derived components, HSC-BANKER® contains only European or US Pharmacopoeia graded ingredients making it suitable for storage of hematopoietic stem cells developed for cell therapy applications. HSC-BANKER® is supplied ready-to-use and requires no special devices, such as a controlled rate freezer, in order to achieve consistently high viabilities following resuscitation from cryopreservation, even over extended long-term storage. HCS-BANKER® significantly increases cell viability while maintaining cell pluripotency, normal karyotype and proliferation ability after freeze-thaw.

Evaluated for endotoxins, pH, osmolarity and mycoplasma contaminants to ensure GMP equivalent quality. HSC-BANKER® builds on the CELLBANKER® range of cryopreservation media for cells, organoids and tissues.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Exhibitor registration opens for 2027 occupational safety and health trade fair in Düsseldorf
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow